Compare RCEL & SOL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RCEL | SOL |
|---|---|---|
| Founded | N/A | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 114.3M | 98.5M |
| IPO Year | N/A | 2008 |
| Metric | RCEL | SOL |
|---|---|---|
| Price | $3.41 | $1.94 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 2 |
| Target Price | ★ $11.75 | $4.50 |
| AVG Volume (30 Days) | 196.2K | ★ 270.2K |
| Earning Date | 11-06-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $72,401,000.00 | $71,226,000.00 |
| Revenue This Year | $13.12 | N/A |
| Revenue Next Year | $27.56 | $45.37 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 20.59 | N/A |
| 52 Week Low | $3.33 | $1.04 |
| 52 Week High | $14.16 | $2.30 |
| Indicator | RCEL | SOL |
|---|---|---|
| Relative Strength Index (RSI) | 36.63 | 68.41 |
| Support Level | $3.33 | $1.89 |
| Resistance Level | $3.58 | $1.95 |
| Average True Range (ATR) | 0.18 | 0.05 |
| MACD | 0.01 | 0.02 |
| Stochastic Oscillator | 17.36 | 96.54 |
Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently in rollout across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.
Emeren Group Ltd is a renewable energy producer. Its portfolio consists of solar projects and Independent Power Producer (IPP) assets, and it also has globalised Battery Energy Storage System (BESS) capacity. The group specializes in the solar project lifecycle, development, and from construction to financing. It has three reportable segments; Solar power project development, EPC services, and Electricity generation. Majority of revenue is From Electricity Generation. The company operates in China, USA, Germany, UK, Spain, France, Poland, Italy, Hungary, Luxembourg. Majority of revenue is from Italy.